Search Results for: "genentech v samsung bioepis bevacizumab"

BPCIA Litigations

The table below chronologically lists the U.S. patent litigations filed under the BPCIA regarding aBLAs for biosimilar products. # Litigation Accused Biosimilar [status] Reference Product Complaint Filed Status/Outcome District Court Appeal 1 Amgen v. Sandoz, No. 14-474 (N.D. Cal.) [consolidated with #7 below] ZARXIO (filgrastim-sndz) [approved; launched] NEUPOGEN [litigation #1]…

Read More